Standard BioTools Inc.LABNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank21
3Y CAGR-4.5%
5Y CAGR-9.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-4.5%/yr
vs -3.5%/yr prior
5Y CAGR
-9.2%/yr
Recent acceleration
Acceleration
-1.0pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$85.33M-51.1%
2024$174.43M+64.0%
2023$106.34M+8.6%
2022$97.95M-25.0%
2021$130.58M-5.5%
2020$138.14M+17.8%
2019$117.24M+3.8%
2018$112.96M+10.8%
2017$101.94M-2.4%
2016$104.45M-